5 mg comprimidos

DRUG4 trials

Sponsors

Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia, Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia, Les Hopitaux Universitaires De Strasbourg, Fundacion Epic, Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Conditions

Acute decompensated heart failureDegree of control coronary risk factors and platelet aggregationHigh cardiovascular risk in HIV patientskidney transplant

Phase 2

A randomised, double-blind, multicenter, placebo-controlled clinical trial of colchicine to reduce coronary artery inflammation in people with HIV. COLCOHIV

Not yet recruitingCTIS2024-520346-39-00

Fundacion Para La Investigacion Biomedica Del Hospital Universitario La PazHigh cardiovascular risk in HIV patients

Target: 104Updated: 2025-04-25

Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock and/or acute respiratory failure: an open multicentric randomized phase IV study

Not yet recruitingCTIS2024-518493-14-00

Les Hopitaux Universitaires De Strasbourgkidney transplant

Target: 212Updated: 2025-11-19

Phase 3

Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure

CompletedCTIS2023-504165-23-00

Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia, Fundacion Para La Formacion E Investigacion Sanitaria De La Region De MurciaAcute decompensated heart failure

Start: 2021-02-08End: 2024-04-30Target: 302Updated: 2023-05-25

CROSS-OVER ANALYSIS OF THE CONTROL OF RISK FACTORS AND ANTIAGGREGATION WITH POLIPILL (POLICROSS TRIAL)

Not yet recruitingCTIS2024-518705-18-00

Fundacion EpicDegree of control coronary risk factors and platelet aggregation

Target: 88Updated: 2024-11-04